Just 11 days after adding a section on medical marijuana to its treatment database, the National Cancer Institute has altered the new page, removing any mention of the evidence that marijuana can diminish and even reverse tumor growth.
In an edit appearing Monday afternoon, NCI replaced a sentence about marijuana’s direct anti-tumor effect with one saying that it is prescribed mainly to control nausea, pain and insomnia for cancer patients, reports Kyle Daly at The Colorado Independent.
The original language, published to the Web on March 17, had read:
The potential benefits of medicinal Cannabis for people living with cancer include antiemetic effects, appetite stimulation, pain relief, and improved sleep. In the practice of integrative oncology, the health care provider may recommend medicinal Cannabis not only for symptom management but also for its possible direct antitumor effect.
After being changed Monday, it now reads:
The potential benefits of medicinal Cannabis for people living with cancer include antiemetic effects, appetite stimulation, pain relief, and improved sleep. Though no relevant surveys of practice patterns exist, it appears that physicians caring for cancer patients who prescribe medicinal Cannabis predominantly do so for symptom management.
Information which acknowledges that marijuana has been used medicinally for thousands of years was left on the site, as were statements regarding cannabinoids and their benefits in ameliorating the side-effects of conventional cancer treatments.
Was Big Pharm behind the changes? Were the pharmaceutical companies protecting their profits derived from harsh and often ineffective chemotherapy?
Neil Rockind and Colin Daniels are Michigan’s best and most visible medical marijuana advocates and defense lawyers. A Super Lawyer recipient and a business Top Lawyer, Neil Rockind is ready to take on your medical marijuana case.